pI: 5.1669 |
Length (AA): 485 |
MW (Da): 54901 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
8 | 311 | 1izn (B) | 2 | 260 | 29.00 | 0 | 0.98 | 0.69 | 0.3 |
370 | 398 | 1zr7 (A) | 10 | 38 | 48.00 | 0.0000019 | 0.97 | 0.75 | -1.4 |
423 | 455 | 1wr7 (A) | 9 | 41 | 9.00 | 0.000000023 | 0.02 | 0.23 | -0.95 |
14 | 308 | 1izn (B) | 8 | 257 | 31.00 | 0 | 1 | 0.781547 | 0.4 |
358 | 397 | 1wr4 (A) | 3 | 34 | 37.00 | 0 | 0.41 | 0.316774 | -0.9 |
366 | 397 | 1e0l (A) | 2 | 33 | 50.00 | 0.0014 | 0.6 | 0.617479 | 0.01 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | metacyclic. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | epimastigote. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_128870)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G71790 | probable F-actin-capping protein subunit beta |
Brugia malayi | Bm1_47000 | F-actin capping protein beta subunit |
Candida albicans | CaO19.12066 | F-actin capping protein beta subunit |
Candida albicans | CaO19.4597 | F-actin capping protein beta subunit |
Caenorhabditis elegans | CELE_M106.5 | Protein CAP-2 |
Dictyostelium discoideum | DDB_G0267374 | subunit of heterodimeric actin capping protein cap32/34 |
Drosophila melanogaster | Dmel_CG17158 | capping protein beta |
Echinococcus granulosus | EgrG_000772300 | F actin capping protein subunit beta |
Echinococcus granulosus | EgrG_000257920 | F actin capping protein subunit beta |
Entamoeba histolytica | EHI_005020 | F-actin capping protein beta subunit, putative |
Echinococcus multilocularis | EmuJ_000257920 | F actin capping protein, beta subunit |
Echinococcus multilocularis | EmuJ_000772300 | F actin capping protein subunit beta |
Homo sapiens | ENSG00000077549 | capping protein (actin filament) muscle Z-line, beta |
Loa Loa (eye worm) | LOAG_04611 | F-actin capping protein beta subunit |
Mus musculus | ENSMUSG00000028745 | capping protein (actin filament) muscle Z-line, beta |
Neospora caninum | NCLIV_061190 | f-actin capping protein beta subunit, putative |
Oryza sativa | 4332978 | Os03g0381200 |
Plasmodium berghei | PBANKA_1232400 | F-actin-capping protein subunit beta |
Plasmodium falciparum | PF3D7_0517600 | F-actin-capping protein subunit beta, putative |
Plasmodium knowlesi | PKNH_1015700 | F-actin-capping protein subunit beta, putative |
Plasmodium vivax | PVX_080370 | F-actin-capping protein subunit beta, putative |
Plasmodium yoelii | PY03888 | F-actin capping protein, beta subunit |
Saccharomyces cerevisiae | YIL034C | F-actin-capping protein subunit beta |
Schistosoma japonicum | Sjp_0005140 | ko:K10365 capping protein (actin filament) muscle Z-line, beta, putative |
Schistosoma mansoni | Smp_186650 | f-actin capping protein beta subunit |
Schmidtea mediterranea | mk4.001101.02 | F-actin-capping protein subunit beta |
Trypanosoma cruzi | TcCLB.506363.60 | f-actin capping protein beta subunit, putative |
Trypanosoma cruzi | TcCLB.506975.49 | f-actin capping protein beta subunit, putative |
Toxoplasma gondii | TGME49_219290 | F-actin-capping protein subunit beta, putative |
Trichomonas vaginalis | TVAG_398750 | f-actin capping protein beta subunit, putative |
Trichomonas vaginalis | TVAG_261590 | f-actin capping protein beta subunit, putative |
Trichomonas vaginalis | TVAG_271840 | f-actin capping protein beta subunit, putative |
Trichomonas vaginalis | TVAG_094060 | f-actin capping protein beta subunit, putative |
Trichomonas vaginalis | TVAG_396060 | f-actin capping protein beta subunit, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_M106.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_M106.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_M106.5 | Caenorhabditis elegans | larval lethal | wormbase |
CELE_M106.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_M106.5 | Caenorhabditis elegans | sterile | wormbase |
PBANKA_1232400 | Plasmodium berghei | Dispensable | plasmo |
TGME49_219290 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.